Journal of Applied Physiology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


J Appl Physiol 79: 2106-2113, 1995;
8750-7587/95 $5.00
This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Pang, C. Y.
Right arrow Articles by Forrest, C. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Pang, C. Y.
Right arrow Articles by Forrest, C. R.

Journal of Applied Physiology, Vol 79, Issue 6 2106-2113, Copyright © 1995 by American Physiological Society


ARTICLES

Vascular effects and mechanism of action of endothelin-1 in isolated perfused pig skin

C. Y. Pang, R. Z. Yang, P. Neligan, N. Xu, C. Chiu, A. Zhong and C. R. Forrest
Research Institute, Hospital for Sick Children, Toronto, Ontario, Canada.

We investigated the vascular effects and mechanism of action of endothelin-1 (ET-1) in the skin by intra-arterial infusion of ET-1 and its precursor Big ET-1 via a direct cutaneous artery in isolated perfused pig skin flaps (6 x 16 cm). The vascular contractivity was studied by monitoring the perfusion pressure in the skin flap. There was evidence to indicate local conversion of Big ET-1 to ET-1 in the pig skin. It was also observed that ET-1 was a potent long-lasting vasoconstrictor with a potency of approximately 10- and 300-fold higher than those of Big ET-1 and norepinephrine, respectively. The vasoconstrictor action of ET-1 was blocked (P < 0.01) by a selective ETA-receptor antagonist (BQ-123 or BQ-610; 10(-7) M) and enhanced (P < 0.05) by a nitric oxide synthase inhibitor (NG-monomethyl-L-arginine or N omega-nitro-L-arginine methyl ester; 10(-5) M). ET-1-induced increase in perfusion pressure was attenuated (P < 0.05) by an L-type Ca(2+)-channel antagonist (nitrendipine, verapamil, or nifedipine; 10(-5) M) and by removal of Ca2+ from the perfusate. ET-1-induced increase in perfusion pressure was also attenuated (P < 0.05) by a phospholipase C inhibitor (neomycin; 10(-2) M), a protein kinase C (PKC) inhibitor (chelerythrine or H-7; 10(-5) M), and an intracellular Ca2+ chelator [1,2-bis(2-aminophenoxy)]ethane-N,N,N',N'-tetraacetic acid (BAPTA); 10(-5) M]. Furthermore, it was observed that the concentration-dependent (5 x 10(-8) to 10(-5) M) increase in perfusion pressure induced by phorbol 12,13-dibutyrate, a PKC activator, was not affected by verapamil (10(-5) M) or removal of Ca2+ from the perfusate. Taken together, these observations suggest that the vasoconstrictor mechanism of ET-1 in the pig skin involved activation of ETA receptors, L-type Ca2+ channels, phospholipase C, and PKC and that the vasoconstrictor effect caused by activation of PKC was independent of L-type Ca2+ channels.


This article has been cited by other articles:


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
H. Ashrafpour, N. Huang, P. C. Neligan, C. R. Forrest, P. D. Addison, M. A. Moses, R. H. Levine, and C. Y. Pang
Vasodilator effect and mechanism of action of vascular endothelial growth factor in skin vasculature
Am J Physiol Heart Circ Physiol, March 1, 2004; 286(3): H946 - H954.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
C. E. Black, N. Huang, P. C. Neligan, R. H. Levine, J. E. Lipa, S. Lintlop, C. R. Forrest, and C. Y. Pang
Effect of nicotine on vasoconstrictor and vasodilator responses in human skin vasculature
Am J Physiol Regulatory Integrative Comp Physiol, October 1, 2001; 281(4): R1097 - R1104.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
C. Y. Pang, H. Xu, N. Huang, C. R. Forrest, T. M. Perreault, and P. C. Neligan
Amplification effect and mechanism of action of ET-1 in U-46619-induced vasoconstriction in pig skin
Am J Physiol Regulatory Integrative Comp Physiol, March 1, 2001; 280(3): R713 - R720.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
J. E. Lipa, P. C. Neligan, T. M. Perreault, J. Baribeau, R. H. Levine, R. J. Knowlton, and C. Y. Pang
Vasoconstrictor effect of endothelin-1 in human skin: role of ETA and ETB receptors
Am J Physiol Heart Circ Physiol, February 1, 1999; 276(2): H359 - H367.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
C. Y. Pang, J. Zhang, H. Xu, J. E. Lipa, C. R. Forrest, and P. C. Neligan
Role and mechanism of endothelin-B receptors in mediating ET-1-induced vasoconstriction in pig skin
Am J Physiol Regulatory Integrative Comp Physiol, October 1, 1998; 275(4): R1066 - R1074.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online